Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. They combine advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic. Their aim is to develop a low-cost, multi-cancer blood test.

Harbinger Health

Pioneering the detection of early cancer.  Harnessing AI and the biology of cancer's origin.

When they're not cranking out the data to support our quest to put the fear of cancer to rest, our data science team (with an assist from our Head of Automation) is out running all the miles! Congratulations to our Harbies who completed the Cambridge Half Marathon recently - Kyle Gowen, Jocelyn Charlton, Jackson Killian, Kade Pettie, Kristy Schlueter-Kuck, and Olga Seltser. We're proud of all that you accomplish both in and out of the office!

#HarbingerHealth #CancerInnovation #MCED #Harbies 

The leaves may be falling outside, but we're not heading for hibernation here at Harbinger - we keep growing! Welcome to our October new hires Ioannis Ladas, Romina Lenci, Charles 'Riggs' Raymond, CPA, Helen Oyinlola, Tracy W., Hawra Al-Rekabi, and Mattie Toolin. We're excited to see all that you achieve here!

Harbinger Health is proud to introduce our Belonging Initiative, which places a strong emphasis on ensuring that every member of our team feels a deep sense of belonging from the moment they join us. We consider belonging to be a fundamental and an ongoing aspect of our company culture. Moreover, we extend this sense of belonging to the accessibility of our products for our patients regardless of socio-economic status.  
 
To underscore our commitment to fostering a culture of belonging, our CEO Steve Hahn has signed the MassBio CEO Pledge, demonstrating our dedication to a more equitable and inclusive life sciences industry. Harbinger Health is excited to collaborate with MassBio and other national partners to actively listen and integrate practical initiatives that advance the cause of belonging. 

#belonging #diversityequtyinclusion #accessibilityinhealthcare #MCED #earlycancerdetection


We had a busy September! Welcome to Apple (Supawadee) Chawanthayatham, Dee Williams, Fangyan Yu, Christine Emery, Elena Goldthwait, Jennifer Zarutskie, Mehul G., and Erik Clement - we are so excited to have you on board.

🎤 "We are tackling three challenges in early screening. The first being, do the tests actually detect early stage cancer? The second big issue is clinical informativeness. We need to be able to give answers to a doctor to adequately take care of a patient. And the third issue is access. So many fell behind during Covid; we need to do a better job on cost and decentralization of care."

Our CEO Steve Hahn shared the stage today at #HLTH2023 for an important conversation on the key obstacles in early cancer detection. 

Metric
Company Name	Harbinger Health
Symbol
MSH ID	COM:HARBINGER-HEALTH
Market	PRIVATE
Sector	Biotechnology
Industry	Healthcare
Country	US
Stage	Series B
Employee Count	73
Website	harbinger-health.com
LinkedIn	harbinger-health
Founders

Metric
Market Cap	115.70M
Enterprise Value
Monthly Web Traffic	381
Web Traffic Growth	1.14
Valuation
Raised Capital	140M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:HARBINGER-HEALTH

Harbinger Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue